Bloomwell Group

Frankfurt-based medical marijuana company Bloomwell Group Gmbh released a survey on cannabis consumption in Germany showing 94% of respondents use cannabis for at least one health reason. Stress relief was the most common reason (60%), followed by sleeping disorders (50.4%) and pain relief (35%). "...

Medical marijuana company Bloomwell Group GmbH released a report Wednesday on Germany's private medical marijuana market. The Frankfurt-based company serves as the centralized digital infrastructure for medical cannabis distribution, consultations and treatment including via telemedicine and...

The German cannabis market is being shaken by its entrepreneurs. In this case, the Frankfurt-based Bloomwell Group GmbH has announced the creation of Germany's largest centralized digital platform for medical cannabis. The platform, aimed at patients, physicians, pharmacies and wholesalers offers...

Editor’s note: This story has been updated to correct the spelling of Anna-Sophia Kouparanis’ name. Since the legalization of medical cannabis in Germany in 2017, the industry has faced notable challenges, chiefly the scarcity of physicians ready to prescribe these treatments. Anna-...

The Bundestag approved partial cannabis legalization in a final floor vote on Friday, making Germany the third country in Europe to legalize adult-use marijuana after Malta and Luxembourg.  Under Germany’s partial cannabis legalization, known as the CanG bill, cannabis will be removed from...

Approximately 21 million adults, or 8.3%, in the U.S. experienced at least one major depressive episode in 2021, with the highest prevalence being among people between 18 and 25, according to data from the National Institute of Mental Health.  A new clinical study offers hope for many people...

George Bernard Shaw once said, “Progress is impossible without change, and those who cannot change their minds cannot change anything.” When it comes to reforming stagnant marijuana attitudes and laws, institutional change needs to keep pace with shifts in society,...

Germany’s federal parliament, the Bundestag, debated for the first time a draft legislation from the Federal Government that would regulate and legalize cannabis. The meeting, postponed last Friday, gave enough time to the bill’s opponents to propose measures that...

For decades, the German cannabis landscape has been bound by prohibitive laws and marked by stigmatization, with the plant's therapeutic potential locked away behind a fortified wall of regulation. But today, the winds of change are blowing through the corridors of power in Berlin, ushering in...

Frankfurt-based medical cannabis holding company Bloomwell Group has closed a multi-million Euro funding round led by Artemis Growth Partners, an American investment fund specializing in impact investing across global cannabis markets. Also participating in this latest funding round are existing...

As cannabis awareness and acceptance take root around the world, a sister-brother team of entrepreneurs in Germany is at the European forefront: Anna-Sophia and Niklas Kouparanis. The siblings are co-founders of the leading medical cannabis holding company, the Bloomwell...

European cannabis market operator Bloomwell Group recently closed a seed funding round of more than $10 million dollars. This is one of the largest seed investments the European cannabis market has seen to date. The investment round was led by U.S.-based Measure 8 Venture Partners, a fund founded...